Tema Heart & Health ETF
HRTS
NASDAQ
Weiss Ratings | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Reward Grade | U | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Valuation | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Price | $28.57 | |||
Company Info | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Tema Global Limited | |||
Manager/Tenure (Years) | Troy Cates (1), Ryan Houlton (1), Yuri Khodjamirian (1), 2 others | |||
Website | -- | |||
Phone Number | -- | |||
Fund Information | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Tema Heart & Health ETF | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Health | |||
Inception Date | Nov 20, 2023 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | -- | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.50% | |||
Dividend | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 1.61% | |||
Asset Allocation | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 1.04% | |||
Stock | 98.96% | |||
U.S. Stock | 79.27% | |||
Non-U.S. Stock | 19.69% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.20% | |||
30-Day Total Return | 0.80% | |||
60-Day Total Return | 2.89% | |||
90-Day Total Return | 3.70% | |||
Year to Date Total Return | 0.05% | |||
1-Year Total Return | -9.92% | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
Price | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | $28.00 | |||
1-Month Low Price | $27.85 | |||
1-Month High Price | $29.28 | |||
52-Week Low Price | $26.25 | |||
52-Week Low Price (Date) | Apr 08, 2025 | |||
52-Week High Price | $35.34 | |||
52-Week High Price (Date) | Sep 19, 2024 | |||
NAV | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
1-Month Low NAV | $27.98 | |||
1-Month High NAV | $29.28 | |||
52-Week Low NAV | $26.30 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $35.28 | |||
52-Week High Price (Date) | Aug 30, 2024 | |||
Beta / Standard Deviation | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Standard Deviation | -- | |||
Balance Sheet | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 47.01M | |||
Operating Ratios | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.75% | |||
Turnover Ratio | 85.00% | |||
Performance | HRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 4.06% | |||
Last Bear Market Total Return | -- | |||